Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ingvar

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Anti-Cancer Drugs|December 5, 1998
Zilascorb(2H), a low-toxicity protein synthesis inhibitor that exhibits signs of anticancer activity in malignant melanomaK A Semb, S Aamdal, E Mette, et al.
British Journal of Cancer|October 29, 2011
Androgen receptor genotypes predict response to endocrine treatment in breast cancer patientsK B Lundin, M Henningson, M Hietala, et al.
Immunology|January 1, 1995
Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopesP Ifversen, C Mårtensson, L Danielsson, et al.
The British Journal of Dermatology|March 6, 2020
Survival in 31 670 patients with thin melanomas: a Swedish population-based studyK Isaksson, R Mikiver, H Eriksson, et al.
Journal of Internal Medicine|March 19, 2016
Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of the Melanoma in Southern Sweden cohortP G Lindqvist, E Epstein, K Nielsen, et al.
International Journal of Cancer|July 15, 1999
Different patterns of chromosomal imbalances in metastasising and non-metastasising primary breast carcinomasA Adeyinka, F Mertens, I Idvall, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2008
Interstitial laser thermotherapy (ILT) of breast cancerK H Haraldsdóttir, K Ivarsson, S Götberg, et al.
Melanoma Research|December 3, 2002
Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation familiesA Måsbäck, H Olsson, J Westerdahl, et al.
The British Journal of Surgery|April 27, 2020
Long-term outcome of pT1a-b, cN0 breast cancer without axillary dissection or staging: a prospective observational study of 1543 womenC Ingvar, J Ahlgren, S Emdin, et al.
Breast Cancer Research and Treatment|January 1, 1996
Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factorsH Olsson, H Jernström, P Alm, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Anti-Cancer Drugs|December 5, 1998
Zilascorb(2H), a low-toxicity protein synthesis inhibitor that exhibits signs of anticancer activity in malignant melanomaK A Semb, S Aamdal, E Mette, et al.
British Journal of Cancer|October 29, 2011
Androgen receptor genotypes predict response to endocrine treatment in breast cancer patientsK B Lundin, M Henningson, M Hietala, et al.
Immunology|January 1, 1995
Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopesP Ifversen, C Mårtensson, L Danielsson, et al.
The British Journal of Dermatology|March 6, 2020
Survival in 31 670 patients with thin melanomas: a Swedish population-based studyK Isaksson, R Mikiver, H Eriksson, et al.
Journal of Internal Medicine|March 19, 2016
Avoidance of sun exposure as a risk factor for major causes of death: a competing risk analysis of the Melanoma in Southern Sweden cohortP G Lindqvist, E Epstein, K Nielsen, et al.
International Journal of Cancer|July 15, 1999
Different patterns of chromosomal imbalances in metastasising and non-metastasising primary breast carcinomasA Adeyinka, F Mertens, I Idvall, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2008
Interstitial laser thermotherapy (ILT) of breast cancerK H Haraldsdóttir, K Ivarsson, S Götberg, et al.
Melanoma Research|December 3, 2002
Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation familiesA Måsbäck, H Olsson, J Westerdahl, et al.
The British Journal of Surgery|April 27, 2020
Long-term outcome of pT1a-b, cN0 breast cancer without axillary dissection or staging: a prospective observational study of 1543 womenC Ingvar, J Ahlgren, S Emdin, et al.
Breast Cancer Research and Treatment|January 1, 1996
Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factorsH Olsson, H Jernström, P Alm, et al.
Pageof 11